GVV858 drug page Clinical trials

Trials with GVV858

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
8Countries
205Planned patients

Showing 1–1 of 1

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Recruiting Phase 1 205 patients NCT07288359

Phase I: Characterize safety and tolerability of GVV858 as a single agent and in combination with fulvestrant or letrozole. Identify dose range for optimization/recommended dose for further clinical evaluation. Phase II: Further character…

United States, Denmark, Germany, Italy and 4 more Dec 2025 – May 2031 Interventional
Combined with: FulvestrantLetrozole

Where the recruiting trials are